Companies
Employees11-50
Funding$2M
Healthcare AIAI ApplicationB2B SaaSSeed$1M-$10M
About
iOrganBio provides an AI-powered manufacturing platform called CellForge for the precision engineering of human cells and organoids. Targeting biopharma partners, the company enables scalable and reproducible outcomes for in vitro modeling, drug discovery, and cell therapies. They monetize through a B2B model, leveraging a proprietary Functional Human CellAtlas for digital blueprints of cell types.
Active Roles
0No active roles right now.
Get notified when they postKey Investors
First Star Ventures, IndieBio, Cape Fear BioCapital, 2ndF, Terasaki Institute, Alix Ventures, SOSV